Deep learning integrates histopathology and proteogenomics at a pan-cancer level

Authors

Joshua M Wang, New York University
Yize Li, Washington University School of Medicine in St. Louis
Li Ding, Washington University School of Medicine in St. Louis
et al.

Journal

Cell Reports Medicine

Publication Date

9-19-2023

Volume

4

Issue

9

First Page

101173

Document Type

Open Access Publication

DOI

10.1016/j.xcrm.2023.101173

Rights and Permissions

Wang JM, Hong R, Demicco EG, Tan J, Lazcano R, Moreira AL, Li Y, Calinawan A, Razavian N, Schraink T, Gillette MA, Omenn GS, An E, Rodriguez H, Tsirigos A, Ruggles KV, Ding L, Robles AI, Mani DR, Rodland KD, Lazar AJ, Liu W, Fenyö D; Clinical Proteomic Tumor Analysis Consortium. Deep learning integrates histopathology and proteogenomics at a pan-cancer level. Cell Rep Med. 2023 Sep 19;4(9):101173. doi: 10.1016/j.xcrm.2023.101173. Copyright 2023 The Author(s). This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).

Recommended Citation

Wang, Joshua M; Li, Yize; Ding, Li; and et al., "Deep learning integrates histopathology and proteogenomics at a pan-cancer level." Cell Reports Medicine. 4, 9. 101173 (2023).
https://digitalcommons.wustl.edu/oa_4/2766

Additional Links

Supplemental material is available for this article at publisher site.